Topoisomerase II Inhibitors

All categories
DBCAT000549Pharmacologic class

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form... A DrugBank category of 48 drugs. 31 of them are approved.

Also known as
DNA Gyrase Inhibitors · DNA Topoisomerase II Inhibitors · DNA Type 2 Topoisomerase Inhibitors · Gyrase Inhibitors, DNA · Inhibitors, DNA Gyrase
Drugs

and 23 more with a free account

What you can answer from here — as of August 24, 2016

48DrugsEach linked to its full drug card
Sign in
39Drug targetsEvery drug–target pair in the class, with bond type
Sign in
6,347Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
15Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Topoisomerase II Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In